TrialCPT: pharmacometrics & systems pharmacology2025

Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis.

Yuki Otani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.